Topical Collection "Topic Advisory Panel Members’ Collection Series: Immunization and Vaccines for Infectious Diseases"

Editors

Department of Biomedical Sciences, University of Pikeville, Coal Building, Office 718, 147 Sycamore Street, Pikeville, KY 41501, USA
Interests: infectious diseases; tuberculosis; vaccines
Special Issues, Collections and Topics in MDPI journals
Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, NY 12180, USA
Interests: yeast-based vaccines; yeast-based screening of chemicals
Special Issues, Collections and Topics in MDPI journals

Topical Collection Information

Dear Colleagues,

Our Topical Collection will be a “Topic Advisory Panel Collection” that will cover all the topics relevant to immunization for infectious diseases. Human history has faced several pandemic threats, including influenza, SARS2, and COVID-19. The big challenge in responding to pandemic diseases is that vaccines may not exist, or existing vaccines may not be effective against them. Therefore, this collection will be an ideal forum where scientists can share their latest research findings on immunization and vaccines related to infectious diseases, particularly Inflenzam, SARS-CoV-2, HIV, and tuberculosis. In this collection, original research articles, case studies, editorials, and reviews are welcome.

We look forward to receiving your manuscript.

Dr. Shumaila Hanif
Dr. Ravinder Kumar
Collection Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine
  • immunization
  • infectious diseases
  • influenza
  • SARS2
  • COVID-19
  • SARS-CoV-2
  • HIV
  • tuberculosis

Published Papers (1 paper)

2023

Article
Evaluation of the Effectiveness of the Policy of Holding the Second Dose of Vaccination: Lessons from the Outbreak in Ho Chi Minh City
Vaccines 2023, 11(2), 293; https://doi.org/10.3390/vaccines11020293 - 29 Jan 2023
Viewed by 1436
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has caused a lot of ethical controversy in the equal provision of healthcare, including vaccination. Therefore, our study was designed to assess the impact of Ho Chi Minh City’s policy to hold the second dose of the [...] Read more.
The coronavirus disease 2019 (COVID-19) pandemic has caused a lot of ethical controversy in the equal provision of healthcare, including vaccination. Therefore, our study was designed to assess the impact of Ho Chi Minh City’s policy to hold the second dose of the COVID-19 vaccine. Using a cross-sectional study design to assess low saturation of peripheral oxygen (SPO2) risk based on vaccination status, we included patients who were confirmed to have SARS-CoV-2 and were treated at home. The stepwise method was used to determine participants’ low SPO2 risk-related factors. The average age of the 2836 respondents was 46.43 ± 17.33 (years). Research results have shown that seven factors are related to the low SPO2 status of participants, including age, sneezing, shortness of breath, coughing, and fainting as COVID-19 symptoms, the number of people living with COVID-19, and a history of lung disease. A statistically significant (p = 0.032) finding in this study was that fully vaccinated patients had a 6% lower risk of low SPO2 compared to the first dose less than 21 days group. This result was similar in the vaccine holder group (p < 0.001). Holding the second dose of the COVID-19 vaccine is associated with a lower SPO2 risk than that of fully vaccinated patients. Therefore, this approach should be considered by governments as it could bring a greater benefit to the community. Full article
Show Figures

Figure 1

Back to TopTop